<DOC>
	<DOCNO>NCT01602679</DOCNO>
	<brief_summary>The rapidity progesterone slow LH ( inference GnRH ) pulse frequency woman unclear . The investigator hypothesize progesterone slow LH pulse frequency within 10 hour . The investigator propose assess randomize , cross-over , placebo-controlled study . Regularly cycle woman without hyperandrogenism admit Clinical Research Unit cycle day 5-9 ( mid-follicular phase ) 10 hour frequent sample study observe LH , FSH , estradiol , progesterone , testosterone . Either oral micronized progesterone suspension placebo administer 0900 h. During subsequent menstrual cycle , subject undergo another study identical first except oral progesterone exchange placebo vice versa accordance crossover design .</brief_summary>
	<brief_title>Acute Effects Progesterone LH Pulses During Follicular Phase ( CRM006 )</brief_title>
	<detailed_description>The rapidity progesterone slow LH ( inference GnRH ) pulse frequency woman unclear . The investigator hypothesize progesterone slow LH pulse frequency within 10 hour . The investigator propose assess randomize , cross-over , placebo-controlled study . Regularly cycle woman without hyperandrogenism admit Clinical Research Unit cycle day 5-9 ( mid-follicular phase ) frequent sample study . Beginning 0900 h , blood LH , FSH , estradiol , progesterone , testosterone obtain 10-hour period . Either oral micronized progesterone ( 100 mg p.o . ) suspension placebo administer 0900 h. During subsequent menstrual cycle , subject undergo another study identical first except oral progesterone exchange placebo vice versa accordance crossover design . The primary endpoint interest LH pulse frequency ; investigator compare LH pulse frequency progesterone administration LH pulse frequency placebo administration .</detailed_description>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Subjects healthy woman regular menstrual cycle evidence hyperandrogenism . Subjects 1830 year old ; investigator use cutoff age 30 year agerelated alteration hypothalamicpituitaryovarian axis uncommon age 30 year . Subjects willing strictly avoid pregnancy ( use nonhormonal method ) time study must willing able provide inform consent . Pregnancy Lactation History allergy progesterone BMI &lt; 18 kg/m2 &gt; 30 kg/m2 ( underweight obesity affect hypothalamicpituitaryovarian function ) Excessive exercise , define routine current engagement either ( ) moderate exercise ( e.g. , brisk walking ) exceed 14 hour per week ( ) vigorous exercise exceed 7 hour week . Clinical hyperandrogenism ( primarily hirsutism ) Abnormally elevate free testosterone DHEAS concentration A previous diagnosis diabetes , fast glucose â‰¥ 126 mg/dl Abnormal TSH ( subject adequately treat hypothyroidism , reflect normal TSH value , exclude ; , new diagnosis hypothyroidism , study least delayed pending appropriate treatment ) ( confirm repeat ) Abnormal prolactin ( confirmed repeat ) Evidence Cushing 's syndrome history physical exam History venous thromboembolism , breast/ovarian/endometrial cancer The investigator exclude woman cancer diagnosis and/or treatment ( exception basal cell squamous skin carcinoma ) unless remain clinically disease free ( base appropriate surveillance ) five year . Women anemia ( hematocrit &lt; 36 % hemoglobin level &lt; 12 g/dl ) treat iron maximum 2 sequential month 1st admission and/or 2nd admission . If remain anemic 2 sequential month ferrous gluconate ( 325 mg bid ) , exclude participation study . Women significant history cardiac pulmonary dysfunction ( e.g. , know suspect congestive heart failure ; know suspect coronary atherosclerosis ; asthma require systemic intermittent corticosteroid ; etc . ) exclude . Women liver enzymes , alkaline phosphatase , bilirubin &gt; 1.5 time upper limit normal ( confirmed repeat ) exclude , exception mild bilirubin elevation accept set know Gilbert 's syndrome . Abnormal sodium potassium concentration ( confirm repeat ) ; bicarbonate concentration &lt; 20 &gt; 30 ( confirm repeat ) Women abnormal renal function ( i.e. , serum creatinine &gt; 1.4 ) exclude ( confirmed repeat ) Due amount blood drawn study , subject body weight &lt; 110 pound exclude study Being study acute effect progesterone hypothalamicpituitary unit , subject must take hormonal medication ( e.g. , oral contraceptive ) medication know affect reproductive axis 60 day prior study study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>